Assessment of chronic liver disease

(canceled)

(canceled)

A device comprising

• (a) at least one measuring unit for determining an amount of a first biomarker being IGFBP3 and an amount of a second biomarker being GGT in a sample of the subject, said at least one measuring unit comprising at least one detection means for the first biomarker and the second biomarker;
• and
• (b) an evaluation unit operably linked to the measuring unit, said evaluation unit comprising a data processor comprising instructions for carrying out a comparison of the amount of the first biomarker and the second biomarker to references and/or for carrying out a calculation of a score for assessing based on the amounts of the biomarkers.

(canceled)

A method for measuring a panel of biomarkers in a subject suspected to suffer from chronic liver disease or suffering from chronic liver disease, the method comprising:

• obtaining a sample from the subject;
• determining a measurement for the panel of biomarkers in the sample, wherein the panel comprises the biomarkers Insulin-like growth factor-binding protein 3 (IGFBP3) and gamma-glutamyltransferase (GGT), wherein the measurement comprises determining a level of each of the biomarkers IGFBP3 and GGT in the panel.